GEN Exclusives

More »

Best of the Web

More »
Sep 15, 2009 (Vol. 29, No. 16)

Biospeleology

URL:www.utexas.edu/tmm/sponsored_sites/biospeleology/index.html
  • Nice photo collections, links
  • Lacks background educational material

Remember the thrills of exploring nature as a child? Whether it was building forts in trees, running through the forest, or climbing the cragged rocks at the beach, the terrain always possessed an element of mystery that inspired the imagination. Well, this sense of excitement and exploration is very much a part of the lives of biospeleologists, people who study the biology of caves and their inhabitants. Biospeleology is co-sponsored by the University of Texas at Austin, the Texas Natural Science Center, and the Missouri Department of Conservation, and it provides an insider’s look at the field. There is a wonderful gallery of cave-dwelling animal photos, organized by taxon. (There is also a separate photo collection—cave biologists at work—that really makes one appreciate the effort that goes in to collecting the photos of the cave critters.) The website includes a list of other biospeleology links, so grab your flashlight and start exploring!

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?